Specialty Pharmacy

By 2014, 8.5% of the global population had diabetes.

Bisphenol A is found in numerous plastic and resin household products.

Specialty pharmacy needs to become a results-based industry that delivers superior health outcomes.

Anti-CD38 monoclonal antibody daratumumab (Darzalex) shows promise for patients with multiple myeloma.

A recent Tecfidera study finds find no rate of relapse of progression in MS patients.

Nanoparticles show an anti-inflammatory effect on the macrophages in IBD treatment.

Blocking the recruitment of blood vessels suppresses small cell lung cancer tumor growth.

Top news of the day from across the health care landscape.

CD4-HIV interactions may mediate type I interferon production.

The cost of disease-modifying antirheumatic drugs for rheumatoid arthritis remains a concern.

Current treatment options for patients who previously failed HCV therapy are limited.

Consuming 2.5 servings of coffee per day found to decrease colorectal cancer development by up to 50%.

Some genetic variants have the potential to affect responses to immunosuppressive drugs that influence organ rejection.

Top news of the day from across the health care landscape.

New technique offers sustained release of antibodies directly to skin cancer tumor.

Afatinib (Gilotrif) shows significant improvements in overall survival and disease progression.

Patients put themselves at risk by not reading active ingredient listings on drug packaging.

Optic neuropathy is common in multiple sclerosis as the immune system destroys myelin and damages the nerves.

Recent advances and updates in oncology and cancer drug development.

HCV-related deaths continued to rise while deaths from 60 other infectious diseases declined.

Compounded hormone medications linked with potential risks and side effects.

Prescription drugs, over-the-counter drugs, and dietary supplements lead to potentially deadly combinations.

Sulindac and erlotinib effectively reduced the total duodenal polyps in patients with familial adenomatous polyposis.

Novel drug RG-101 could shorten the treatment time for hepatitis C virus (HCV) infection to 4 weeks.

Zepatier achieves sustained virologic response rate of 99.2% during a 12 to 16 week treatment course in patients with HCV.

Directories include lists of clinicians, providers, and health care facilities within health plan networks.

Helping patients navigate manufacturer prescription assistance programs found to lower hospitalization costs.

Sugary drinks found to triple the risk of developing prostate cancer.